Stephanie Klenotich, Ph.D.

T32 Research Fellow, Animal Models of Anorexia Nervosa

Knapp Center for Medical Research
924 E. 57th St., MC3077, Rm R022
Chicago, IL 60637
Phone: 773-702-6369

Education and Training

  • PhD, Neurobiology, University of Chicago, 2013
  • BS, Brain and Cognitive Science, University of Rochester, 2007

Research Interests

  • Animal models of psychiatric disorders
  • Activity-based anorexia mouse model of anorexic-like behaviors
  • Neurobiology of anorexic behaviors
  • Novel pharmacological treatments for anorexia nervosa

Society Memberships

  • Society for Neuroscience
  • American Association of Pharmaceutical Scientists

Selected Publications

  • Opal, M, Klenotich, S, Morais, et al (2013). Serotonin 2C receptor antagonists induce fast-onset antidepressant effects. Molecular Psychiatry (accepted).
  • Woehrle NS, Klenotich SJ, Jamnia N, Ho EV, Dulawa SC. Effects of chronic fluoxetine treatment on serotonin 1B receptor-induced deficits in delayed alternation. Psychopharmacology. 2013 Feb 3.
  • Piletz JE, Klenotich S, Lee KS et al. Putative Agmatinase Inhibitor for Hypoxic-Ischemic New Born Brain Damage. Neurotox Res. 2013 Jan 19.
  • Klenotich, SJ, Seiglie, M. P., et. al. (2012). Olanzapine, but not fluoxetine, treatment increases survival in activity-based anorexia in mice. Neuropsychopharmacology. 37(7):1620-31.
  • Klenotich SJ and Dulawa SC (2012). The Activity-Based Anorexia Mouse Model. In: Kobeissy FH (ed). Psychiatric Disorders: Methods and Protocols. 2012. 829 (4): 377-393. Humana Press: New York.